Focuses on researching and developing live biotherapeutic products by analyzing the human microbiome. Engages in both preclinical and clinical-stage programs across various therapeutic areas, aiming to explore microbial interactions with human health through proprietary scientific platforms and collaborations.
2014
United Kingdom
51 - 200 employees
Pharmaceuticals
$500K - 1M in revenue